CurieDx
CurieDx is a Baltimore-based digital health startup developing a smartphone app that screens for strep throat from user images, targeting individual consumers and underserved populations with limited access to traditional diagnostic care. Founded in 2023 and led by CEO Therese Canares.
- Company typePrivate
- Founded2023
- HeadquartersBaltimore, United States
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What CurieDx does
CurieDx is a Baltimore-based digital health startup founded in 2023 that has developed a mobile application capable of screening for strep throat using smartphone images. The product is positioned as a point-of-care diagnostic tool designed to reduce time to treatment, curb antibiotic misuse from misdiagnosis, and extend diagnostic access to populations underserved by traditional laboratory infrastructure. The company operates with a headcount of 1-10 and is led by founder and CEO Therese Canares.
The company's technology is delivered as a smartphone-based screening application rather than a traditional laboratory diagnostic, leveraging the ubiquity of consumer mobile devices as the imaging and distribution platform. Distribution is direct-to-consumer through mobile app stores, consistent with a product-led growth motion targeting individual users presenting with sore throat symptoms and, separately, underserved populations in diagnostic deserts. Capital sources to date have been modest and early-stage: a $325,000 round in mid-2023 from an undisclosed investor, TEDCO (Maryland's technology development corporation) in early 2023, and engagement with Springboard Enterprises in September 2023. In April 2026, CurieDx was selected for PORTENT Year 3 funding from Cornell University's Center for Point-of-Care Technologies, joining four other next-generation point-of-care diagnostic developers in a non-dilutive grant program that provides institutional validation alongside research funding.
The revenue model is described as subscription-recurring typical of point-of-care diagnostic apps, but no public pricing, customer counts, or revenue figures are disclosed, and no patents, regulatory clearances, or third-party clinical validation studies are evidenced in the available data. The company has not disclosed senior AI/ML hires, proprietary model details, or integration partnerships, leaving the depth of its diagnostic algorithmic capability unverified beyond the core smartphone-screening claim.
CurieDx firmographics
Firmographics- Name
- CurieDx
- Website
- https://curiedx.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CurieDx is a Baltimore-based digital health startup developing a smartphone app that screens for strep throat from user images, targeting individual consumers and underserved populations with limited access to traditional diagnostic care. Founded in 2023 and led by CEO Therese Canares.
- Ownership category
- akta.pro rank
CurieDx industry classification
Industry- Product category
- Point-of-Care Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Diagnostic & Triage Decision Support (HLACAGAA)
- akta.pro secondary industry
- Urgent Care + ePrescribing & Lab/Imaging Ordering Telehealth Platforms (HLALAJAL)
Keywords
Where CurieDx is headquartered
LocationHeadquarters
- HQ city
- Baltimore
- HQ country
- United States
- HQ region
- North America
Markets served
CurieDx business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Diagnostic Testing Services: Mobile-based diagnostic screening tool for strep throat, likely operating on a per-test or subscription model typical of point-of-care diagnostic applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
CurieDx product offering
Product offeringCore offering
CurieDx provides a smartphone-based mobile application that screens for strep throat using smartphone imaging, enabling point-of-care diagnostic testing for consumers with sore throat symptoms. The tool allows users to perform rapid at-home screening without laboratory visits or specialized equipment, supporting faster treatment decisions and reducing antibiotic misuse through accurate pre-treatment diagnosis.
Product overview
CurieDx offers a smartphone-based strep throat screening tool as its core product. This point-of-care diagnostic technology enables users to screen for strep throat using their smartphone, improving diagnostic access in underserved populations and reducing issues like antibiotic misuse and delayed treatment. The company is developing this technology with support from PORTENT, a Center for Point-of-Care Technologies at Cornell University.
Differentiator
Problem solved
Functional benefit
Products and services
- Smartphone-Based Strep Throat Screening App A mobile diagnostic application that uses smartphone imaging to screen for strep throat, enabling rapid point-of-care testing for individuals with sore throat symptoms without requiring laboratory visits or specialized equipment.
Quantifiable outcome
- Improves diagnostic access in underserved populations
- +1 more outcomes
Companies that use CurieDx
Customer profileSegments2 records
Ideal customer profiles2 records
CurieDx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
CurieDx partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PORTENT (Center for Point-of-Care Technologies at Cornell University)corePORTENT selected CurieDx for Year 3 funding among five next-generation point-of-care diagnostic technologies. PORTENT is a Center for Point-of-Care Technologies at Cornell University that supports innovation in diagnostic technologies targeting underserved populations. The partnership provides funding and institutional validation for CurieDx's smartphone-based strep throat screening tool development.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
CurieDx competitors and assessment
Company assessmentOthers
- Ro (Roman): Ro is a direct-to-consumer telehealth and pharmacy company that has expanded into at-home diagnostics and condition-specific virtual care. It represents the broader DTC care ecosystem in which CurieDx's sore throat screening tool would compete for consumer mindshare and reimbursement.
- Tyto Care: Tyto Care offers a handheld device paired with telehealth for remote physical and ear/throat examinations. While hardware-based, it serves the same remote diagnostic exam of sore throat and respiratory conditions that CurieDx aims to address via smartphone.
Direct peers
- Scanwell Health: Scanwell Health offers smartphone-based at-home diagnostic tests, most notably for UTIs, using computer vision on test strips. It is directly comparable to CurieDx as a smartphone-camera-enabled diagnostic screening company targeting consumer-friendly infectious disease triage.
- Healthy.io: Healthy.io converts smartphone cameras into clinical-grade diagnostic tools, including at-home UTI testing and chronic kidney disease screening. It shares CurieDx's core thesis of using ubiquitous smartphone hardware to deliver lab-grade diagnostics without specialized equipment.
- Cue Health: Cue Health provides direct-to-consumer molecular diagnostic testing for respiratory and other infectious diseases. While hardware-based rather than smartphone-camera-based, it competes for the same consumer point-of-care diagnostic use cases and health system partnerships.
- Everlywell: Everlywell offers a broad portfolio of at-home diagnostic test kits for consumers, including infectious disease, hormone, and wellness panels. It is comparable to CurieDx as a consumer-facing diagnostic brand competing for the same health-conscious, convenience-seeking buyer.
- LetsGetChecked: LetsGetChecked provides at-home diagnostic testing with mail-in sample collection for infectious diseases, sexual health, and chronic conditions. It represents the broader at-home diagnostic category that smartphone-native tools like CurieDx aim to disrupt on speed and convenience.
Emerging players
- K Health: K Health offers AI-driven primary care and symptom triage through a mobile app, connecting consumers to clinicians based on data-driven assessment. It overlaps with CurieDx on the smartphone-based triage and diagnostic decision support use case for low-acuity conditions.
- Babylon Health: Babylon Health provides AI-powered symptom checking and triage within a telehealth platform. While broader in scope, it shares CurieDx's underlying category of digital diagnostic decision support guiding patients toward appropriate next steps.
- Ada Health: Ada Health provides AI-driven symptom assessment and triage used by consumers, providers, and health systems. It is thematically comparable to CurieDx as a software-first clinical decision support and triage tool targeting the same low-acuity symptom evaluation pathway.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
CurieDx social profiles
Digital presenceCurieDx financial estimates
Financial estimateRevenue estimate
Valuation estimate
CurieDx leadership team
Management profileNumber of profiles
Profiles1 record
CurieDx funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CurieDx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CurieDx
What does CurieDx do?
CurieDx provides a smartphone-based mobile application that screens for strep throat using smartphone imaging, enabling point-of-care diagnostic testing for consumers with sore throat symptoms. The tool allows users to perform rapid at-home screening without laboratory visits or specialized equipment, supporting faster treatment decisions and reducing antibiotic misuse through accurate pre-treatment diagnosis.
When was CurieDx founded?
CurieDx was founded in 2023. It employs 1 to 10 people.
Where is CurieDx based?
CurieDx is headquartered in Baltimore, United States, in the North America region.
How does CurieDx make money?
One revenue line is on record: diagnostic Testing Services.
Who are CurieDx's main competitors?
Others on record are Ro (Roman) and Tyto Care. Direct peers are Scanwell Health, Healthy.io, Cue Health, Everlywell and LetsGetChecked. Emerging players are K Health, Babylon Health and Ada Health.
Does CurieDx have an API?
No public API is recorded for CurieDx.
What industry is CurieDx in?
CurieDx's product category is Point-of-Care Diagnostics. Its primary akta.pro industry code is HLACAGAA, Diagnostic & Triage Decision Support, with a secondary code of HLALAJAL, Urgent Care + ePrescribing & Lab/Imaging Ordering Telehealth Platforms. Its NAICS code is 621511 and its SIC code is 7372.